Dr. Stephen W. Doggett, MD

Dr. Doggett practices at Mivip Orange County Multispeciality Surgery Center & Sleep Center in Tustin, California.

Dr. Doggett's NPI, 1982675021, was assigned on January 27, 2006. Dr. Doggett graduated from USF Health Morsani College of Medicine in 1980. Dr. Doggett holds California license G49856.

Dr. Doggett's primary practice is Mivip Orange County Multispeciality Surgery Center & Sleep Center, at 14642 Newport Ave, Tustin, CA 92780 in Orange County. The practice phone is (714) 505-5005.

Dr. Doggett's primary practice is Mivip Orange County Multispeciality Surgery Center & Sleep Center in Tustin, California. Dr. Doggett is also affiliated with Providence Mission Hospital. The medical group on file is Stephen W. Doggett, M.D., P.A. Dmand AI also links Dr. Doggett to 5 more group practices and clinics and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doggett practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Doggett's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Doggett is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Doggett's licenses on file in 15 states: California, Mississippi, Nevada, Washington, Michigan, Oregon, Utah, Indiana, Kentucky, Ohio, Alaska, Hawaii, Missouri, Nebraska and Arizona.

Dmand AI lists bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation and pancreatic cancer radiation among the conditions Dr. Doggett treats.

CMS data shows 3,569 Medicare services from Dr. Doggett across 20 procedure codes in 2024, for 206 Medicare patients. Medicare paid $716,306 for them. Every service was in an office.

CMS counts 206 Medicare patients who saw Dr. Doggett in 2024. The largest group is 75 to 84, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Doggett's median patient age at 71, with 47% women.

In 2024, Dr. Doggett wrote 135 Medicare Part D claims for 44 patients. 95% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $314 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Doggett for performance year 2024, reported as part of a group. Dr. Doggett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Doggett as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Doggett, published from 2016 to 2024. 2016 was the busiest year, with 2. The most frequent topics are Brachytherapy, Tomography, X-Ray Computed and Palladium. Dr. Doggett has published most often in J Contemp Brachytherapy. Dr. Doggett's most frequent co-authors are Shigeru Chino, MD, Erick Alfonso Mafong, MD and Mark Andrew Willoughby, MD.

CMS Open Payments shows 17 general payments to Dr. Doggett from 5 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 72% of the total. Elekta, Inc. paid the most, $29,036.

Dmand AI lists 1 award for Dr. Doggett.

Dr. Doggett graduated from USF Health Morsani College of Medicine in 1980.

Dr. Doggett is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.